ACLARIS THERAPEUTICS
1.1400
17-April-25 15:45:00
15 minutes delayed
Stocks
+0.0100
+0.88%
Today's range
1.0800 - 1.1500
ISIN
N/A
Source
NASDAQ
-
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
03 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update
02 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
27 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
26 Aug 2021 15:01:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
05 Aug 2021 06:00:02 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
08 Jul 2021 06:00:00 By Nasdaq GlobeNewswire
-
Aclaris Announces Pricing of Public Offering of Common Stock
09 Jun 2021 18:55:14 By Nasdaq GlobeNewswire
-
Aclaris Announces Proposed Public Offering of Common Stock
08 Jun 2021 15:15:00 By Nasdaq GlobeNewswire
-
08 Jun 2021 06:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
17 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics Reports First Quarter 2021 Financial Results and Provides a Corporate Update
07 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
15 Mar 2021 06:00:01 By Nasdaq GlobeNewswire
-
25 Feb 2021 06:00:04 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
22 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
10 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
Aclaris Announces Pricing of Public Offering of Common Stock
20 Jan 2021 07:45:00 By Nasdaq GlobeNewswire
-
Aclaris Announces Proposed Public Offering of Common Stock
19 Jan 2021 15:01:00 By Nasdaq GlobeNewswire
-
19 Jan 2021 06:00:00 By Nasdaq GlobeNewswire